Page last updated: 2024-10-16

butyric acid and Myelodysplastic Syndromes

butyric acid has been researched along with Myelodysplastic Syndromes in 1 studies

Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shen, H1
Chen, Z1
Ding, X1
Qi, X1
Cen, J1
Wang, Y1
Yao, L1
Chen, Y1

Other Studies

1 other study available for butyric acid and Myelodysplastic Syndromes

ArticleYear
BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:6

    Topics: Acetylation; Adolescent; Adult; Aged; Aged, 80 and over; Apoptosis; Blotting, Western; Butyric Acid;

2014